Invention Grant
- Patent Title: Inhibitors of activin receptor-like kinase
-
Application No.: US16293317Application Date: 2019-03-05
-
Publication No.: US10669277B2Publication Date: 2020-06-02
- Inventor: Kevin J. Wilson , Josh Waetzig
- Applicant: Blueprint Medicines Corporation
- Applicant Address: US MA Cambridge
- Assignee: Blueprint Medicines Corporation
- Current Assignee: Blueprint Medicines Corporation
- Current Assignee Address: US MA Cambridge
- Agency: McCarter & English, LLP
- Agent Steven G. Davis; Wei Song
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D519/00
Abstract:
Described herein are compounds that inhibit ALK2 and its mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.
Public/Granted literature
- US20200031830A1 INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE Public/Granted day:2020-01-30
Information query
